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A. Saratzis,* I. Lazaridis, A. Philippides and D. Kiskinis1st Department of Surgery, University of Aristotle of Thessaloniki, Thessaloniki, GreeceAtherosclerotic lesions of the thoracic aorta and particularly mobile mural thrombi constitute a rare but important source of
cerebral and peripheral emboli. Conventional treatment of such pathologies includes systematic anticoagulation therapy and
surgical thromboendarterectomy, with potential segmental replacement of the thoracic aorta using synthetic grafts. We
report the successful covering of a mobile thoracic aortic thrombus using a commercially available endograft (Endofit) in a
patient presented with multiple peripheral emboli. The endovascular treatment of such lesions constitutes a new alternative
treatment particularly effective and safe that decreases considerably both operational time and surgical risk.Keywords: Endovascular; Mobile thoracic aortic thrombi; Mural thrombi; Endofit; Atherosclerosis; Thoracic aorta.Introduction
Atherosclerotic lesions of the thoracic aorta and
particularly the mobile mural thrombi constitutes
an important source of cerebral and peripheral
emboli.1–3 In 1990, Tunink et al. reported three
patients with protruding atheromatic plagues,
which resulted into aortic mobile mural thrombi.4
Since then, numerous publications indicate a signifi-
cant correlation between atherosclerotic disease of
the thoracic aorta and embolic episodes. Transeso-
phageal cardiac ultrasonography has disclosed ather-
osclerotic lesions and thrombi of the thoracic aorta in
26–27% of the patients presented with embolic
episodes.1,3,5,6 Conventional treatment of these
lesions involves systematic anticoagulation therapy
and surgical thromboendarterectomy, with potential
segmental replacement of the thoracic aorta using
synthetic grafts. We report the successful covering of
a mobile mural thrombus of the descending thoracic
aorta, using a thoracic endograft in a patient
presented with multiple peripheral embolic episodes.
The endovascular repair of these lesions with theing author. A. Saratzis, Farmaki 9A Str., Panorama N.
niki 55236, Greece.
: saratzis@germanosnet.gr
2005 Elsevier Ltd. Open access under CC BY-NC-ND license.deployment of an endograft constitutes a new
alternative treatment, particularly effective and safe,
which decreases considerably both operational time
and surgical risk.Case Report
A 63-year-old male patient presented at the emer-
gency department with diffuse abdominal pain of
acute onset and vomiting. The clinical examination of
the patient indicated a soft abdomen, without
muscular guarding or palpable masses but with
diffuse mild tenderness. The patient’s history also
included intermittent claudication (Fontaine II)
within the last month (ankle–branchial index 0.55
on the right, 0.65 on the left) and eczema of the upper
limbs. The patient was a smoker (one pack daily for
48 years) with moderate alcohol consumption. The
initial spiral abdominal computed tomography (CT)
and angiography demonstrated multiple visceral
infarcts—sizeable spleen infarct, bilateral renal
infarcts—more extensive in the left kidney—small
liver infarct and occlusions of the left common iliac
and right superficial femoral artery. Moreover, digital
substruction angiography demonstrated an intimalEJVES Extra 11, 32–35 (2006)
doi:10.1016/j.ejvsextra.2005.12.001, available online at http://www.sciencedirect.com on
Fig. 2. Angiography demonstrated an intimal abnormality
with an adjacent filling defect arising from the aortic arch,
opposite to the origin of the left subclavian artery.
Fig. 1. CT-scan of the abdomen showing spleen and renal
infarcts.
Fig. 3. CT scan showing a mural lesion of the thoracic aorta at t
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from the aortic arch, opposite to the origin of the left
subclavian artery, up to 4 cm, in the wall of the
descending thoracic aorta (Figs. 1 and 2). No
pathological findings were found in the electrocar-
diogram. Further, investigation with transthoracic
cardiac ultrasound did not demonstrate any signifi-
cant pathological findings (absence of clots in cardiac
cavities, normal myocardial contraction, EF 60%).
Thrombophilia screen tests were negative. Spiral
thoracic CT/CT-angiography disclosed a mural
lesion of the thoracic aorta at the end of the aortic
arch and the proximal descending aorta, with local
dissection or mural thrombus constituting a possible
diagnosis (Fig. 3). During the hospitalization, the
patient suddenly experienced intense pain at the left
hypochondrium with onset of fever and an increase
in white cells count. A second abdominal/thoracic
spiral CT demonstrated the presence of new infracts,
despite the anticoagulation treatment. An infract
expansion was also noticed, with new infracts in
the spleen and increase of the hypodense areas in
both kidneys. The liver remained unchanged.
Transesophageal echocardiography disclosed a large
mobile mural thrombus of the descending thoracic
aorta that was adherent to a calcified protruding
atherosclerotic plaque (Fig. 4). We decided to cover
the lesion with the deployment of an ebdoluminal
thoracic stent-graft. The right common femoral and
left brachial arteries were surgically exposed. After
systemic administration of heparin, 6 Fr sheaths were
introduced in the exposed vessels. We advanced two
guidewires—under fluoroscopic control—up to the
aortic arch. These included one standard 0.035 in.
wire, through the brachial artery, and a stiff Supra-
Core 0.035 in. wire (Guidant) with long non-trau-
matic tip through the right common femoral artery.
An angiography catheter was introduced throughhe end of the aortic arch and the proximal descending aorta.
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Fig. 4. Transesophageal echocardiography showing a large
mobile mural thrombus of the descending thoracic aorta.
N. Saratzis et al.34the brachial artery for contrast injection and acting as
marker of the origin of the left subclavian artery
during the stent-graft deployment. An Endofit stent-
graft 40mm!18 cm with a proximal bare stent was
used (Endofit, Endomed, Phoenix, AZ, USA, with the
technical assistance of V. Tympanides, Greece). The
graft was deployed proximal to the origin of the left
subclavian artery, completely covering the athero-
sclerotic plaque and the mural mobile thrombus.
Operative time was 50 min, while 120 ml of contrast
media was used. The postoperative period was
uneventful and the patient was discharged from the
hospital on the 5th day, on antiplatelet medication
(clopidogrel). Plain X-ray and CT scan of the thoraxFig. 5. Postoperative CT-scan showing complete stent
EJVES Extra Vol 11, March 2006disclosed good graft position during the follow up
(Figs. 5 and 6).Discussion
Until recently, mobile mural thrombi were rarely
diagnosed. Transesophageal cardiac ultrasonography
has proven to be a very sensitive method in the
diagnosis of this pathology. The first report was made
in 1990 by Tunink et al., referring to three patients with
aortic mobile mural thrombi, arising from protruding
atherosclerotic plaques.4 They were diagnosed by
transesophageal ultrasonography, while previously
they had been usually diagnosed either during
cardiothoracic operations, or post mordem.7 Indeed,
in a series of post mortem autopsies, in a study
concluded by Machleder et al. in 1986, the existence of
mural thrombi of the thoracic aorta was noted in 0.09%
of the total 10.671 autopsies executed. However, it was
not specified whether they were adherent or mobile
thrombi.8 Diagnosis of the underlying cause of the
embolism associated with the complicated athero-
sclerotic lesions of the thoracic aorta, is essential for
the early treatment. Criado et al. reported a recurrent
mobile thoracic thrombus, despite surgical thrombect-
omy and systemic anticoagulation, treated with endo-
vascular exclusion of the descending thoracic aorta-graft deployment without endoluminal thrombus.
Fig. 6. Postoperative 3D reconstruction showing stent-graft
deployment proximal to the origin of the left subclavian
artery.
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homemade endovascular graft and a Palmaz stent.9 In
our case, a commercially available endoluminal stent-
graft (Endofit) was used. The Endofit graft consists of a
nitinol metal frame incorporated in PTFE with a
proximal bare stent support. This particular design
was used for the endovascular treatment of athero-
sclerotic lesions complicated with mural thrombi for
the very first time. With this approach, thoracotomy,
aortic clamping and cardiopulmonary by-pass are
avoided, eliminating all the inherent risks for the
respiratory system, cardiac and renal function and
spinal cord perfusion. Potential risks of the method are
embolization during the endoluminal manipulations
and cardiac-arrest. The systemic administration of
heparin intraproceduraly and postoperative anti-coagulation treatment can decrease the danger of
embolization. On the contrary, the operational time
and surgical risk appear to be low, making the method
attractive for the treatment of this rare pathology.References
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